Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire AiSP launches Singapore’s first ladies in cybersecurity mentorship programme to bolster country’s digital defence
HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment 2.